1Moreno R,Fernandez C,Hernandez R,et al.Drug-eluting stent thrombosis:results from a pooled analysis including 10 randomized studies[J].J Am Coll Cardiol,2005,45:954-959.
2Schampaert E,Moses JW,Schofer J,et al.Sirolimus-eluting stents at two years:a pooled analysis of SIRIUS,E-SIRIUS,and C-SIRIUS with emphasis on late revascularizations and stent thromboses[J].Am J Cardiol,2006,98(1):36-41.
3Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents[J].JAMA,2005,293:2126-2130.
4Duk-Woo P,Seong-Wook P,Kyoung-Ha P,et al.Frequency of/and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up[J].Am J Cardiol,2006,98(3):352-356.
8Pfisterer M, Brunner-La Rocca HP, Rickenbacher P,et al. Long-term benefit-risk balance of dmg-eluting vs. bare-metal stents in daily practice:does stent diameter matter? Three-year follow-up of BAS- KET [ J ]. Eur Heart J,2009,30 ( 1 ) : 16 - 24.
9Page M, Doucet M, Eisenberg MJ, et al. Temporal trends in revascu- larization and outcomes after acute myocardial infarction among the very elderly[ J]. CMAJ ,2010,182 ( 13 ) : 1415 - 1420.
10Hsu PC,Juo SH, Su HM,et al. Predictor of poor coronary collaterals in elderly population with significant coronary artery disease[ J 1. Am J Med Sci,2013,346(4) :269 -272.
